Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001181431-03-013395
Filing Date
2003-07-09
Accepted
2003-07-08 18:31:56
Documents
1
Period of Report
2003-07-03

Document Format Files

Seq Description Document Type Size
1 FORM 4 OF RICHARD J. HINDIN rrd12836.html 4  
1 FORM 4 OF RICHARD J. HINDIN rrd12836.xml 4 6535
  Complete submission text file 0001181431-03-013395.txt   8455
Mailing Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814
Business Address 3 BETHESDA METRO CENTER SUITE 700 BETHESDA MD 20814 3019611992
REGENERX BIOPHARMACEUTICALS INC (Issuer) CIK: 0000707511 (see all company filings)

EIN.: 521253406 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address
Business Address ALPHA 1 BIOMEDICALS INC 3 BETHESDA METRO CENTER BETHSEDA MD 20814 3019611992
HINDIN RICHARD J (Reporting) CIK: 0001125613 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-15070 | Film No.: 03779033